The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study-Reference-Cited by-同舟云学术

The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study

Published:2019-01 Issue: Volume:76 Page:76-81
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Vijenthira Abi^ORCID,Premkumar Devyani,Callum Jeannie,Lin Yulia,Wells Richard A.,Chodirker Lisa,Lenis Martha,Mamedov Alexandre,Buckstein Rena

Funder

Celgene Canada and Crashley Estate

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. The incidence and impact of thrombocytopenia in myelodysplastic syndromes;Kantarjian;Cancer,2007

2. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes;Neukirchen;Eur. J. Haematol.,2009

3. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

5. Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications;Gupta;Leuk. Res.,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet transfusion;Current Opinion in Hematology;2024-09-06

2. Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms;Cancers;2024-04-19

3. Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey;European Journal of Haematology;2023-12-20

4. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes;European Journal of Haematology;2023-07-15

5. Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia;Journal of Cancer Research and Clinical Oncology;2023-04-15